{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:59:09Z","timestamp":1781323149045,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2016209176"],"award-info":[{"award-number":["H2016209176"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bone.2019.02.024","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T23:37:58Z","timestamp":1551483478000},"page":"17-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Salmon calcitonin exerts better preventive effects than celecoxib on lumbar facet joint degeneration and long-term tactile allodynia in rats"],"prefix":"10.1016","volume":"127","author":[{"given":"Yu","family":"Gou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faming","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muwei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglie","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiangang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litao","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5239-3561","authenticated-orcid":false,"given":"Liu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2019.02.024_bb0005","doi-asserted-by":"crossref","unstructured":"Becker A, Held H, Redaelli M, Strauch K, Chenot JF, Leonhardt C, et al. Low back pain in primary care: costs of care and prediction of future health care utilization. Spine (Phila Pa 1976) 2010; 35: 1714\u20131720.","DOI":"10.1097\/BRS.0b013e3181cd656f"},{"key":"10.1016\/j.bone.2019.02.024_bb0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nrrheum.2012.199","article-title":"Osteoarthritis of the spine: the facet joints","volume":"9","author":"Gellhorn","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bone.2019.02.024_bb0015","doi-asserted-by":"crossref","unstructured":"Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163\u20132196.","DOI":"10.1016\/S0140-6736(12)61729-2"},{"key":"10.1016\/j.bone.2019.02.024_bb0020","doi-asserted-by":"crossref","unstructured":"Kim JS, Ali MH, Wydra F, Li X, Hamilton JL, An HS, et al. Characterization of degenerative human facet joints and facet joint capsular tissues. Osteoarthr. Cartil. 2015; 23: 2242\u20132251.","DOI":"10.1016\/j.joca.2015.06.009"},{"key":"10.1016\/j.bone.2019.02.024_bb0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s002560050503","article-title":"MR imaging and CT in osteoarthritis of the lumbar facet joints","volume":"28","author":"Weishaupt","year":"1999","journal-title":"Skelet. Radiol."},{"key":"10.1016\/j.bone.2019.02.024_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrrheum.2012.198","article-title":"Facet joint pain--advances in patient selection and treatment","volume":"9","author":"Cohen","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bone.2019.02.024_bb0035","doi-asserted-by":"crossref","unstructured":"Yeh TT, Wu SS, Lee CH, Wen ZH, Lee HS, Yang Z, et al. The short-term therapeutic effect of recombinant human bone morphogenetic protein-2 on collagenase-induced lumbar facet joint osteoarthritis in rats. Osteoarthr. Cartil. 2007; 15: 1357\u20131366.","DOI":"10.1016\/j.joca.2007.04.019"},{"key":"10.1016\/j.bone.2019.02.024_bb0040","doi-asserted-by":"crossref","unstructured":"Yeh TT, Wen ZH, Lee HS, Lee CH, Yang Z, Jean YH, et al. Intra-articular injection of collagenase induced experimental osteoarthritis of the lumbar facet joint in rats. Eur. Spine J. 2008; 17: 734\u2013742.","DOI":"10.1007\/s00586-008-0594-0"},{"key":"10.1016\/j.bone.2019.02.024_bb0045","doi-asserted-by":"crossref","unstructured":"Kim JS, Kroin JS, Buvanendran A, Li X, van Wijnen AJ, Tuman KJ, et al. Characterization of a new animal model for evaluation and treatment of back pain due to lumbar facet joint osteoarthritis. Arthritis Rheum. 2011; 63: 2966\u20132973.","DOI":"10.1002\/art.30487"},{"key":"10.1016\/j.bone.2019.02.024_bb0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0929-6646(11)60024-7","article-title":"Rat model of lumbar facet joint osteoarthritis associated with facet-mediated mechanical hyperalgesia induced by intra-articular injection of monosodium iodoacetate","volume":"110","author":"Gong","year":"2011","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.bone.2019.02.024_bb0055","doi-asserted-by":"crossref","unstructured":"Chen Y, Hu Y, Yu YE, Zhang X, Watts T, Zhou B, et al. Subchondral trabecular rod loss and plate thickening in the development of osteoarthritis. J. Bone Miner. Res. 2018; 33: 316\u2013327.","DOI":"10.1002\/jbmr.3313"},{"key":"10.1016\/j.bone.2019.02.024_bb0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bone.2005.08.007","article-title":"Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis","volume":"38","author":"Hayami","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2019.02.024_bb0065","doi-asserted-by":"crossref","unstructured":"Hayami T, Pickarski M, Wesolowski GA, McLane J, Bone A, Destefano J, et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum. 2004; 50: 1193\u20131206.","DOI":"10.1002\/art.20124"},{"key":"10.1016\/j.bone.2019.02.024_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18050931","article-title":"Peripheral nerve fibers and their neurotransmitters in osteoarthritis pathology","volume":"18","author":"Grassel","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bone.2019.02.024_bb0075","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/00007632-199306150-00014","article-title":"Substance P innervation of lumbar spine facet joints","volume":"18","author":"Beaman","year":"1993","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.bone.2019.02.024_bb0080","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.joca.2013.03.011","article-title":"Calcitonin delays the progress of early-stage mechanically induced osteoarthritis. In vivo, prospective study","volume":"21","author":"Kyrkos","year":"2013","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bone.2019.02.024_bb0085","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.joca.2011.01.008","article-title":"Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover","volume":"19","author":"Nielsen","year":"2011","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bone.2019.02.024_bb0090","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.joca.2004.08.005","article-title":"Treatment with calcitonin prevents the net loss of collagen, hyaluronan and proteoglycan aggregates from cartilage in the early stages of canine experimental osteoarthritis","volume":"12","author":"El Hajjaji","year":"2004","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bone.2019.02.024_bb0095","doi-asserted-by":"crossref","unstructured":"Bagger YZ, Tanko LB, Alexandersen P, Karsdal MA, Olson M, Mindeholm L, et al. Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis. Bone 2005; 37: 425\u2013430.","DOI":"10.1016\/j.bone.2005.04.032"},{"key":"10.1016\/j.bone.2019.02.024_bb0100","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1002\/art.22075","article-title":"Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis","volume":"54","author":"Manicourt","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2019.02.024_bb0105","doi-asserted-by":"crossref","unstructured":"Karsdal MA, Byrjalsen I, Henriksen K, Riis BJ, Lau EM, Arnold M, et al. The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study. Osteoarthr. Cartil. 2010; 18: 150\u2013159.","DOI":"10.1016\/j.joca.2009.08.004"},{"key":"10.1016\/j.bone.2019.02.024_bb0110","doi-asserted-by":"crossref","unstructured":"Jevsevar DS, Brown GA, Jones DL, Matzkin EG, Manner PA, Mooar P, et al. The American academy of orthopaedic surgeons evidence-based guideline on: treatment of osteoarthritis of the knee, 2nd edition. J. Bone Joint Surg. Am. 2013; 95: 1885\u20131886.","DOI":"10.2106\/00004623-201310160-00010"},{"key":"10.1016\/j.bone.2019.02.024_bb0115","doi-asserted-by":"crossref","unstructured":"Panahifar A, Jaremko JL, Tessier AG, Lambert RG, Maksymowych WP, Fallone BG, et al. Development and reliability of a multi-modality scoring system for evaluation of disease progression in pre-clinical models of osteoarthritis: celecoxib may possess disease-modifying properties. Osteoarthr. Cartil. 2014; 22: 1639\u20131650.","DOI":"10.1016\/j.joca.2014.06.013"},{"key":"10.1016\/j.bone.2019.02.024_bb0120","doi-asserted-by":"crossref","unstructured":"Ou Y, Tan C, An H, Jiang D, Quan Z, Tang K, et al. Selective COX-2 inhibitor ameliorates osteoarthritis by repressing apoptosis of chondrocyte. Med. Sci. Monit. 2012; 18: Br247\u2013252.","DOI":"10.12659\/MSM.882901"},{"key":"10.1016\/j.bone.2019.02.024_bb0125","doi-asserted-by":"crossref","unstructured":"Jiang D, Zou J, Huang L, Shi Q, Zhu X, Wang G, et al. Efficacy of intra-articular injection of celecoxib in a rabbit model of osteoarthritis. Int. J. Mol. Sci. 2010; 11: 4106\u20134113.","DOI":"10.3390\/ijms11104106"},{"key":"10.1016\/j.bone.2019.02.024_bb0130","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2165\/11208240-000000000-00000","article-title":"Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis","volume":"71","author":"McCormack","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.bone.2019.02.024_bb0135","doi-asserted-by":"crossref","unstructured":"Tian FM, Yang K, Wang WY, Luo Y, Li SY, Song HP, et al. Calcitonin suppresses intervertebral disk degeneration and preserves lumbar vertebral bone mineral density and bone strength in ovariectomized rats. Osteoporos. Int. 2015; 26: 2853\u20132861.","DOI":"10.1007\/s00198-015-3202-2"},{"key":"10.1016\/j.bone.2019.02.024_bb0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bone.2019.02.024_bb0145","doi-asserted-by":"crossref","unstructured":"Kalichman L, Li L, Kim DH, Guermazi A, Berkin V, O'Donnell CJ, et al. Facet joint osteoarthritis and low back pain in the community-based population. Spine (Phila Pa 1976) 2008; 33: 2560\u20132565.","DOI":"10.1097\/BRS.0b013e318184ef95"},{"key":"10.1016\/j.bone.2019.02.024_bb0150","doi-asserted-by":"crossref","unstructured":"Liu YD, Liao LF, Zhang HY, Lu L, Jiao K, Zhang M, et al. Reducing dietary loading decreases mouse temporomandibular joint degradation induced by anterior crossbite prosthesis. Osteoarthr. Cartil. 2014; 22: 302\u2013312.","DOI":"10.1016\/j.joca.2013.11.014"},{"key":"10.1016\/j.bone.2019.02.024_bb0155","doi-asserted-by":"crossref","unstructured":"Wu G, Ringkamp M, Murinson BB, Pogatzki EM, Hartke TV, Weerahandi HM, et al. Degeneration of myelinated efferent fibers induces spontaneous activity in uninjured C-fiber afferents. J. Neurosci. 2002; 22: 7746\u20137753.","DOI":"10.1523\/JNEUROSCI.22-17-07746.2002"},{"key":"10.1016\/j.bone.2019.02.024_bb0160","author":"U.S. Food and Drug Administration"},{"key":"10.1016\/j.bone.2019.02.024_bb0165","doi-asserted-by":"crossref","unstructured":"Kim JS, Ahmadinia K, Li X, Hamilton JL, Andrews S, Haralampus CA, et al. Development of an experimental animal model for lower back pain by percutaneous injury-induced lumbar facet joint osteoarthritis. J. Cell. Physiol. 2015; 230: 2837\u20132847.","DOI":"10.1002\/jcp.25015"},{"key":"10.1016\/j.bone.2019.02.024_bb0170","doi-asserted-by":"crossref","unstructured":"Shuang F, Zhu J, Song K, Hou S, Liu Y, Zhang C, et al. Establishment of a rat model of adjuvant-induced osteoarthritis of the lumbar facet joint. Cell Biochem. Biophys. 2014; 70: 1545\u20131551.","DOI":"10.1007\/s12013-014-0091-5"},{"key":"10.1016\/j.bone.2019.02.024_bb0175","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.spinee.2017.11.009","article-title":"Three-dimensional visualization and pathologic characteristics of cartilage and subchondral bone changes in the lumbar facet joint of an ovariectomized mouse model","volume":"18","author":"Wu","year":"2017","journal-title":"Spine J."},{"key":"10.1016\/j.bone.2019.02.024_bb0180","doi-asserted-by":"crossref","unstructured":"Shuang F, Hou SX, Zhu JL, Liu Y, Zhou Y, Zhang CL, et al. Establishment of a rat model of lumbar facet joint osteoarthritis using intraarticular injection of urinary plasminogen activator. Sci. Rep. 2015; 5: 9828.","DOI":"10.1038\/srep09828"},{"key":"10.1016\/j.bone.2019.02.024_bb0185","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2019.02.024_bb0190","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/284873","article-title":"The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis","volume":"2013","author":"Maldonado","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bone.2019.02.024_bb0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13238-010-0002-5","article-title":"The role of ADAMTSs in arthritis","volume":"1","author":"Lin","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.bone.2019.02.024_bb0200","doi-asserted-by":"crossref","unstructured":"Dai MW, Chu JG, Tian FM, Song HP, Wang Y, Zhang YZ, et al. Parathyroid hormone(1-34) exhibits more comprehensive effects than celecoxib in cartilage metabolism and maintaining subchondral bone micro-architecture in meniscectomized guinea pigs. Osteoarthr. Cartil. 2016; 24: 1103\u20131112.","DOI":"10.1016\/j.joca.2016.01.007"},{"key":"10.1016\/j.bone.2019.02.024_bb0205","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.joca.2006.10.012","article-title":"Effect of calcitonin in early and late stages of experimentally induced osteoarthritis. A histomorphometric study","volume":"15","author":"Papaioannou","year":"2007","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bone.2019.02.024_bb0210","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1359\/JBMR.040609","article-title":"Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency","volume":"19","author":"Behets","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.02.024_bb0215","doi-asserted-by":"crossref","unstructured":"Greco KV, Nalesso G, Kaneva MK, Sherwood J, Iqbal AJ, Moradi-Bidhendi N, et al. Analyses on the mechanisms that underlie the chondroprotective properties of calcitonin. Biochem. Pharmacol. 2014; 91: 348\u2013358.","DOI":"10.1016\/j.bcp.2014.07.034"},{"key":"10.1016\/j.bone.2019.02.024_bb0220","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.molimm.2017.05.002","article-title":"Calcitonin protects chondrocytes from lipopolysaccharide-induced apoptosis and inflammatory response through MAPK\/Wnt\/NF-kappaB pathways","volume":"87","author":"Zhang","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bone.2019.02.024_bb0225","doi-asserted-by":"crossref","unstructured":"Wang L, Zhao R, Shi X, Wei T, Halloran BP, Clark DJ, et al. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro. Bone 2009; 45: 309\u2013320.","DOI":"10.1016\/j.bone.2009.04.203"},{"key":"10.1016\/j.bone.2019.02.024_bb0230","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/00016480410017710","article-title":"Substance P upregulates osteoclastogenesis by activating nuclear factor kappa B in osteoclast precursors","volume":"125","author":"Sohn","year":"2005","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.bone.2019.02.024_bb0235","doi-asserted-by":"crossref","unstructured":"Manicourt DH, Altman RD, Williams JM, Devogelaer JP, Druetz-Van Egeren A, Lenz ME, et al. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions. Arthritis Rheum. 1999; 42: 1159\u20131167.","DOI":"10.1002\/1529-0131(199906)42:6<1159::AID-ANR12>3.0.CO;2-Q"},{"key":"10.1016\/j.bone.2019.02.024_bb0245","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/01.brs.0000255094.08805.2f","article-title":"Does facet joint inflammation induce radiculopathy?: an investigation using a rat model of lumbar facet joint inflammation","volume":"32","author":"Tachihara","year":"2007","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.bone.2019.02.024_bb0250","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pain.2011.09.007","article-title":"Partial medial meniscectomy produces osteoarthritis pain-related behaviour in female C57BL\/6 mice","volume":"153","author":"Knights","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.bone.2019.02.024_bb0255","doi-asserted-by":"crossref","unstructured":"Bedaiwi MK, Sari I, Wallis D, O'Shea F D, Salonen D, Haroon N, et al. Clinical efficacy of celecoxib compared to acetaminophen in chronic nonspecific low Back pain: results of a randomized controlled trial. Arthritis Care Res. 2016; 68: 845\u2013852.","DOI":"10.1002\/acr.22753"},{"key":"10.1016\/j.bone.2019.02.024_bb0260","doi-asserted-by":"crossref","first-page":"71s","DOI":"10.1016\/S8756-3282(02)00714-7","article-title":"Analgesic effects of calcitonin","volume":"30","author":"Lyritis","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2019.02.024_bb0265","doi-asserted-by":"crossref","first-page":"80s","DOI":"10.1016\/S8756-3282(02)00701-9","article-title":"Possible mechanisms of the analgesic action of calcitonin","volume":"30","author":"Azria","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2019.02.024_bb0270","doi-asserted-by":"crossref","unstructured":"Yeh CB, Weng SJ, Chang KW, Chan JY, Huang SM, Chu TH, et al. Calcitonin alleviates hyperalgesia in osteoporotic rats by modulating serotonin transporter activity. Osteoporos. Int. 2016; 27: 3355\u20133364.","DOI":"10.1007\/s00198-016-3652-1"},{"key":"10.1016\/j.bone.2019.02.024_bb0275","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.maturitas.2015.04.004","article-title":"Biomarkers for osteoarthritis: can they be used for risk assessment? A systematic review","volume":"82","author":"Hosnijeh","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.bone.2019.02.024_bb0280","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.joca.2016.12.016","article-title":"Osteoarthritis year in review 2016: biomarkers (biochemical markers)","volume":"25","author":"Mobasheri","year":"2017","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bone.2019.02.024_bb0285","doi-asserted-by":"crossref","unstructured":"Van Spil WE, Welsing PM, Bierma-Zeinstra SM, Bijlsma JW, Roorda LD, Cats HA, et al. The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK. Osteoarthr. Cartil. 2015; 23: 1388\u20131397.","DOI":"10.1016\/j.joca.2015.03.023"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219300754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219300754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:40:01Z","timestamp":1762659601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328219300754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":56,"alternative-id":["S8756328219300754"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2019.02.024","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salmon calcitonin exerts better preventive effects than celecoxib on lumbar facet joint degeneration and long-term tactile allodynia in rats","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2019.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}